RECRUITING

Methadone and Quality of Postoperative Recovery

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Patients undergoing cardiac surgery often experience moderate to severe pain in the early postoperative period. A number of methods have been used to help control pain after surgery; however, each of these techniques adds additional costs and risks. A simple and effective way to decrease this pain is to administer a long-acting opioid in the operating room. Methadone is a opioid that can produce analgesia (pain relief) that lasts up to 48 hours when given in large doses (0.3 to 0.4 mg/kg). Previous studies have demonstrated that both pain and requirements for analgesic medications are significantly reduced for up to three days after surgery if methadone is given at induction (the start) of anesthesia. In the study that was performed at Evanston Hospital, cardiac surgical patients who were given methadone also appeared to "feel better" after surgery compared to those given a standard or typical intraoperative opioid. The aim of this randomized clinical trial is to determine whether overall quality of postoperative recovery can be enhanced if methadone is given in the operating room. Quality of recovery will be determined by using a validated scoring system, the QoR 40, which will be given to patients to complete on the first three days after surgery.

Official Title

Methadone and Quality of Postoperative Recovery

Quick Facts

Study Start:2018-12-25
Study Completion:2021-07-25
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03168958

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 90 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * All patients presenting for elective cardiac surgery with CPB will be eligible for enrollment
  1. * Preoperative renal failure requiring dialysis or severe renal dysfunction (serum creatinine \> 2.0 mg/dL)
  2. * Significant hepatic dysfunction (liver function tests \> 2 times upper normal limit)
  3. * Pulmonary disease necessitating home oxygen therapy
  4. * Preoperative requirement for inotropic agents or intraaortic balloon pump to maintain hemodynamic stability
  5. * Allergy to methadone or fentanyl
  6. * Significant preoperative pain requiring treatment with opioids or recent history of opioid abuse
  7. * Inability to speak or read the English language or neurologic conditions that may impair the ability to complete the QoR 40 questionnaire.

Contacts and Locations

Study Contact

Glenn S Murphy, MD
CONTACT
847-570-2760
dgmurphy2@yahoo.com

Principal Investigator

Glenn S Murphy, MD
PRINCIPAL_INVESTIGATOR
NorthShore University HealthSystem

Study Locations (Sites)

NorthShore University HealthSystem
Evanston, Illinois, 60201
United States

Collaborators and Investigators

Sponsor: NorthShore University HealthSystem

  • Glenn S Murphy, MD, PRINCIPAL_INVESTIGATOR, NorthShore University HealthSystem

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2018-12-25
Study Completion Date2021-07-25

Study Record Updates

Study Start Date2018-12-25
Study Completion Date2021-07-25

Terms related to this study

Additional Relevant MeSH Terms

  • Quality of Recovery Scores